Literature DB >> 21488601

The markers of interplay between the music therapist and the high risk full term infant.

Helen Shoemark1, Denise Grocke.   

Abstract

The purpose of this research was to discover the markers of interplay between the music therapist and the medically fragile newborn infant. Video footage of 3 infants was selected to exemplify 3 significant events in the therapeutic process. Four expert reviewers viewed the footage and completed a video-cued discussion with the therapist/ researcher. Reviews and discussions were collated with the therapist-researcher's post-session notes to create rich descriptions from which the articulated and inferred behaviors of both therapist and infant were thematically analyzed. The outcome was 14 sets of behaviors used by the medically fragile newborn infants to indicate availability for interplay and 20 sets of behaviors the therapist used in response to the infants. The interaction between these behaviors provided 7 markers of interplay between the music therapist and the medically fragile newborn infant.

Entities:  

Mesh:

Year:  2010        PMID: 21488601     DOI: 10.1093/jmt/47.4.306

Source DB:  PubMed          Journal:  J Music Ther        ISSN: 0022-2917


  3 in total

1.  How musical engagement promotes well-being in education contexts: the case of a young man with profound and multiple disabilities.

Authors:  Katrina S McFerran; Helen Shoemark
Journal:  Int J Qual Stud Health Well-being       Date:  2013-08-07

2.  Music Is Life-Follow-Up Qualitative Study on Parental Experiences of Creative Music Therapy in the Neonatal Period.

Authors:  Friederike Barbara Haslbeck; Lars Schmidli; Hans Ulrich Bucher; Dirk Bassler
Journal:  Int J Environ Res Public Health       Date:  2021-06-21       Impact factor: 3.390

3.  The Effect of a Voice-Centered Psycho-Educational Program on Maternal Self-Efficacy: A Feasibility Study.

Authors:  Helen Shoemark; Marie Dahlstrøm; Oscar Bedford; Lauren Stewart
Journal:  Int J Environ Res Public Health       Date:  2021-03-04       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.